VISTARIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vistaril, and what generic alternatives are available?
Vistaril is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in VISTARIL is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vistaril
A generic version of VISTARIL was approved as hydroxyzine hydrochloride by CHARTWELL RX on April 12th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VISTARIL?
- What are the global sales for VISTARIL?
- What is Average Wholesale Price for VISTARIL?
Summary for VISTARIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 3 |
Patent Applications: | 4,112 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VISTARIL |
What excipients (inactive ingredients) are in VISTARIL? | VISTARIL excipients list |
DailyMed Link: | VISTARIL at DailyMed |
![VISTARIL drug patent expirations Drug patent expirations by year for VISTARIL](/p/graph/s/t/VISTARIL-patent-expirations.png)
![Drug Prices for VISTARIL](/p/graph/drug-price/VISTARIL.png)
![Drug Sales Revenue Trends for VISTARIL](/p/graph/drug-sales-revenues/VISTARIL.png)
Recent Clinical Trials for VISTARIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sultan Qaboos University | Phase 4 |
University of Colorado, Denver | N/A |
Stanford University | N/A |
Pharmacology for VISTARIL
Drug Class | Antihistamine |
Mechanism of Action | Histamine Receptor Antagonists |
US Patents and Regulatory Information for VISTARIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | VISTARIL | hydroxyzine pamoate | CAPSULE;ORAL | 011459-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | VISTARIL | hydroxyzine hydrochloride | INJECTABLE;INJECTION | 011111-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | VISTARIL | hydroxyzine pamoate | CAPSULE;ORAL | 011459-004 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | VISTARIL | hydroxyzine pamoate | CAPSULE;ORAL | 011459-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | VISTARIL | hydroxyzine pamoate | SUSPENSION;ORAL | 011795-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | VISTARIL | hydroxyzine hydrochloride | INJECTABLE;INJECTION | 011111-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |